These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27003282)

  • 1. Optimization of the Production of Inactivated Clostridium novyi Type B Vaccine Using Computational Intelligence Techniques.
    Aquino PL; Fonseca FS; Mozzer OD; Giordano RC; Sousa R
    Appl Biochem Biotechnol; 2016 Jul; 179(5):895-909. PubMed ID: 27003282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phage conversion of Clostridium novyi type A (author's transl)].
    Schallehn G; Eklund MW; Brandis H
    Zentralbl Bakteriol A; 1980 Jun; 247(1):95-100. PubMed ID: 7434996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.
    Eklund MW; Poysky FT; Peterson ME; Meyers JA
    Infect Immun; 1976 Sep; 14(3):793-803. PubMed ID: 965096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clostridium novyi type B alpha toxin by cell culture systems.
    Borrmann E; Schulze F
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):275-80. PubMed ID: 10397311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.
    Eklund MW; Poysky FT; Meyers JA; Pelroy GA
    Science; 1974 Nov; 186(4162):456-8. PubMed ID: 4606682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Molecular and Biochemical Identification of Alpha Toxin in Local Isolated
    Emadi A; Pourbakhsh SA; Fathi Najafi M; Jamshidian M; Amini K
    Arch Razi Inst; 2022 Oct; 77(5):1769-1777. PubMed ID: 37123142
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of an enzyme immunoassay for the detection of Clostridium novyi type B alpha toxin.
    Pietrzykowski E; Cox J; Zachariou M; MacGregor A
    Biologicals; 1991 Oct; 19(4):293-8. PubMed ID: 1797041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines.
    Viana Brandi I; Domenici Mozzer O; Jorge EV; Vieira Passos FJ; Lopes Passos FM; Cangussu AS; Macedo Sobrinho E
    Bioprocess Biosyst Eng; 2014 Sep; 37(9):1737-42. PubMed ID: 24573216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of alpha-toxin produced by Clostridium novyi type A.
    Ball DW; Van Tassell RL; Roberts MD; Hahn PE; Lyerly DM; Wilkins TD
    Infect Immun; 1993 Jul; 61(7):2912-8. PubMed ID: 8514395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Production to Protect Animals Against Pathogenic Clostridia.
    Zaragoza NE; Orellana CA; Moonen GA; Moutafis G; Marcellin E
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31514424
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious necrotic hepatitis caused by Clostridium novyi type B in a horse: case report and review of the literature.
    Nyaoke AC; Navarro MA; Beingesser J; Uzal FA
    J Vet Diagn Invest; 2018 Mar; 30(2):294-299. PubMed ID: 29224513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunity and injection-site reactions in cattle vaccinated with a multivalent clostridial vaccine administered via subcutaneous injection or via transdermal needle-free injection.
    Woolums AR; Ensley DT; Tanner PA; Fankhauser R; Shen J; Songer JG; Leard AT; Milward FW; Pence ME; Hurley DJ
    Am J Vet Res; 2011 Aug; 72(8):1124-9. PubMed ID: 21801072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology and diagnosis of clostridial hepatitis in animals.
    Navarro MA; Uzal FA
    J Vet Diagn Invest; 2020 Mar; 32(2):192-202. PubMed ID: 31735127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological changes in human embryonic lung fibroblasts caused by cytotoxins of various Clostridium species].
    Schallehn G; Wolff MH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):367-78. PubMed ID: 3376617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant infection of Clostridium novyi (A, B) and Clostridium sordellii in mice.
    el Sanousi SM; Abdelrahman SB; Osman A
    Rev Elev Med Vet Pays Trop; 1987; 40(3):243-5. PubMed ID: 3453511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Toxigenesis of Clostridium onvyi type A. 1. Communication: production of alpha-toxin in vitro (author's transl)].
    Schallehn G
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):91-9. PubMed ID: 1163166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the catalytic domain of Clostridium novyi alpha-toxin.
    Busch C; Schömig K; Hofmann F; Aktories K
    Infect Immun; 2000 Nov; 68(11):6378-83. PubMed ID: 11035748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.